Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015, Article ID 397046, 4 pages
http://dx.doi.org/10.1155/2015/397046
Case Report

Vertigo as a Predominant Manifestation of Neurosarcoidosis

1Department of Medicine, New Jersey Medical School Rutgers, The State University of New Jersey, 185 South Orange Avenue, Newark, NJ 07103, USA
2Department of Pathology and Laboratory Medicine, New Jersey Medical School Rutgers, The State University of New Jersey, 185 South Orange Avenue, Newark, NJ 07103, USA
3Division of Allergy, Immunology, and Rheumatology, New Jersey Medical School Rutgers, The State University of New Jersey, 185 South Orange Avenue, Newark, NJ 07103, USA

Received 24 January 2015; Accepted 26 March 2015

Academic Editor: Jagdish Butany

Copyright © 2015 Tasnim F. Imran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Nozaki and M. A. Judson, “Neurosarcoidosis: clinical manifestations, diagnosis and treatment,” Presse Medicale, vol. 41, no. 6, part 2, pp. e331–e348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Hoitsma, C. G. Faber, M. Drent, and O. P. Sharma, “Neurosarcoidosis: a clinical dilemma,” The Lancet Neurology, vol. 3, no. 7, pp. 397–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. K. Gerke, “Morbidity and mortality in sarcoidosis,” Current Opinion in Pulmonary Medicine, vol. 20, no. 5, pp. 472–478, 2014. View at Publisher · View at Google Scholar
  4. R. N. Schwendimann, M. K. Harris, D. G. Elliott et al., “Neurosarcoidosis: clinical features, diagnosis, and management,” American Journal of Therapeutics, vol. 20, no. 3, pp. 292–299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. F. G. Joseph and N. J. Scolding, “Neurosarcoidosis: a study of 30 new cases,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 3, pp. 297–304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Panselinas, L. Halstead, R. J. Schlosser, and M. A. Judson, “Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement,” Southern Medical Journal, vol. 103, no. 9, pp. 870–875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Delaney, “Bedside diagnosis of vertigo: value of the history and neurological examination,” Academic Emergency Medicine, vol. 10, no. 12, pp. 1388–1395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Traccis, G. F. Zoroddu, M. T. Zecca, T. Cau, M. A. Solinas, and R. Masuri, “Evaluating patients with vertigo: bedside examination,” Neurological Sciences, vol. 25, supplement, no. 1, pp. S16–S19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Hoyle, C. Jablonski, and H. B. Newton, “Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations,” The Neurohospitalist, vol. 4, no. 2, pp. 94–101, 2014. View at Publisher · View at Google Scholar
  10. M. Mijajlovic, M. Mirkovic, V. Mihailovic-Vucinic, V. Aleksic, and N. Covickovic-Sternic, “Neurosarcoidosis: two case reports with multiple cranial nerve involvement and review of the literature,” Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 158, no. 4, pp. 662–667, 2014. View at Publisher · View at Google Scholar
  11. J. Q. Yu, H. Zhuang, A. Mavi, and A. Alavi, “Evaluating the role of fluorodeoxyglucose PET imaging in the management of patients with sarcoidosis,” PET Clinics, vol. 1, no. 2, pp. 141–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Terushkin, B. J. Stern, M. A. Judson et al., “Neurosarcoidosis: presentations and management,” The Neurologist, vol. 16, no. 1, pp. 2–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. B. J. O'Reilly and E. H. Burrows, “VIIIth cranial nerve involvement in sarcoidosis,” The Journal of Laryngology & Otology, vol. 109, no. 11, pp. 1089–1093, 1995. View at Google Scholar · View at Scopus
  14. R. P. Baughman, E. E. Lower, D. A. Bradley, L. A. Raymond, and A. Kaufman, “Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial,” Chest, vol. 128, no. 2, pp. 1062–1067, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Callejas-Rubio, L. López-Pérez, and N. Ortego-Centeno, “Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis,” Therapeutics and Clinical Risk Management, vol. 4, no. 6, pp. 1305–1313, 2008. View at Google Scholar · View at Scopus
  16. P. Bhat, R. A. Cervantes-Castañeda, P. P. Doctor, F. Anzaar, and C. S. Foster, “Mycophenolate mofetil therapy for sarcoidosis-associated uveitis,” Ocular Immunology and Inflammation, vol. 17, no. 3, pp. 185–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. R. Maneiro, E. Salgado, J. J. Gomez-Reino, and L. Carmona, “Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review,” Seminars in Arthritis and Rheumatism, vol. 42, no. 1, pp. 89–103, 2012. View at Publisher · View at Google Scholar · View at Scopus